Novo Nordisk surged 7.1% at the end of Tuesday, after the company's Wegovy diet pills were approved by the US Food and Drug Administration, boosting the prospects of the weight loss market.

Novo Nordisk surged 7.1% at the end of Tuesday, after the company's Wegovy diet pills were approved by the US Food and Drug Administration, boosting the prospects of the weight loss market.